Dr Frederique Tholozan

I am the Business Development Lead for Magnitude Biosciences, a CRO based in the North of England. Our C. elegans automated imaging assays can inform on the safety and efficacy profile of candidates compounds prior to rodent studies. We particularly support drug development for microbiome, ageing, neurodegeneration and toxicity applications.